Regulation of cholesterol and sphingomyelin metabolism by amyloid-beta and presenilin.
about
Presenilin-1 uses phospholipase D1 as a negative regulator of beta-amyloid formation.Increased expression of cholesterol 24S-hydroxylase results in disruption of glial glutamate transporter EAAT2 association with lipid rafts: a potential role in Alzheimer's diseaseLipoprotein receptors and cholesterol in APP trafficking and proteolytic processing, implications for Alzheimer's diseaseAmyloid precursor protein regulates brain apolipoprotein E and cholesterol metabolism through lipoprotein receptor LRP1Amyloidosis in Retinal Neurodegenerative DiseasesProtein prenylation and synaptic plasticity: implications for Alzheimer's diseaseCholesterol balance in prion diseases and Alzheimer's diseaseAxonal transport of APP and the spatial regulation of APP cleavage and function in neuronal cellsRoles and regulation of neutral sphingomyelinase-2 in cellular and pathological processesThe Impact of Vitamin E and Other Fat-Soluble Vitamins on Alzheimer´s DiseaseCeramides in Alzheimer's Disease: Key Mediators of Neuronal Apoptosis Induced by Oxidative Stress and Aβ AccumulationInterleukin-1 beta impairs brain derived neurotrophic factor-induced signal transductionATP-binding cassette transporter A1 mediates the beneficial effects of the liver X receptor agonist GW3965 on object recognition memory and amyloid burden in amyloid precursor protein/presenilin 1 mice.Clues to neuro-degeneration in Niemann-Pick type C disease from global gene expression profilingCholesterol-modifying strategies for Alzheimer's disease.New Alzheimer amyloid beta responsive genes identified in human neuroblastoma cells by hierarchical clustering.Increase in sphingolipid catabolic enzyme activity during aging.Inherent anti-amyloidogenic activity of human immunoglobulin gamma heavy chainsCross-talk of membrane lipids and Alzheimer-related proteins.Oxidative Stress, Synaptic Dysfunction, and Alzheimer's Disease.The role of exon shuffling in shaping protein-protein interaction networks.Endoplasmic reticulum stress mediates amyloid β neurotoxicity via mitochondrial cholesterol traffickingAcid sphingomyelinase modulates the autophagic process by controlling lysosomal biogenesis in Alzheimer's disease.Elevated stearoyl-CoA desaturase in brains of patients with Alzheimer's disease.Lipid rafts participate in aberrant degradative autophagic-lysosomal pathway of amyloid-beta peptide in Alzheimer's diseaseMolecular insights into amyloid regulation by membrane cholesterol and sphingolipids: common mechanisms in neurodegenerative diseasesAmyloid precursor protein (APP) mediated regulation of ganglioside homeostasis linking Alzheimer's disease pathology with ganglioside metabolism.Cerebrospinal fluid sphingolipids, β-amyloid, and tau in adults at risk for Alzheimer's disease.Immunogenic properties of amyloid beta oligomers.Oxidative lipid modification of nicastrin enhances amyloidogenic γ-secretase activity in Alzheimer's disease.Ceramide and Related-Sphingolipid Levels Are Not Altered in Disease-Associated Brain Regions of APP and APP/PS1 Mouse Models of Alzheimer's Disease: Relationship with the Lack of Neurodegeneration?Core-shell upconversion nanoparticle - semiconductor heterostructures for photodynamic therapy.Plasmalogen synthesis is regulated via alkyl-dihydroxyacetonephosphate-synthase by amyloid precursor protein processing and is affected in Alzheimer's disease.The intracellular threonine of amyloid precursor protein that is essential for docking of Pin1 is dispensable for developmental function.Regulation of phosphatidic Acid metabolism by sphingolipids in the central nervous systemPathological and physiological functions of presenilins.Elevation in sphingomyelin synthase activity is associated with increases in amyloid-beta peptide generation.Intracellular APP Domain Regulates Serine-Palmitoyl-CoA Transferase Expression and Is Affected in Alzheimer's Disease.Alterations of the sphingolipid pathway in Alzheimer's disease: new biomarkers and treatment targets?Upregulation of PGC-1α expression by Alzheimer's disease-associated pathway: presenilin 1/amyloid precursor protein (APP)/intracellular domain of APP
P2860
Q24541447-6D8C6949-F0E2-4051-A6F9-7B7347DEFA0BQ24620476-D9E8CEE1-2852-448C-B959-085F5E751585Q24650450-44720682-D808-41BD-85C1-DE0C48DFA659Q24672149-837C0471-AE11-45C4-A9DA-F62C950B5BD1Q26739839-C9F3C213-711B-4B0B-8CA5-9AD429409A48Q26858942-966681A4-0BCE-4D68-A684-FF88C2B5062DQ27002948-1A62BFC7-8035-435F-860F-979A65280242Q27022080-2150AB4A-2615-49F6-B51A-F76D8F1FA3E8Q27022944-280DB085-F9FB-46D9-B2FA-030BC77C889CQ28074531-8AF4A877-E6AF-4D45-A169-FBC608A51558Q28087030-9B9F4FC1-1336-40B0-B4B1-677646AC0261Q28576073-FAA73528-39F0-45D7-BB51-70FE9B1EBE7DQ30497102-8AFA4707-A495-4C35-A596-D65F8C6104F2Q33267280-2B0BAD65-90F7-4499-B0D6-0010416080B5Q33347051-28E726BA-824A-4879-B748-A69420154C80Q33496736-86176310-CDA2-46F2-8327-BCC8995D53C7Q33555622-29634EE8-3A6E-4ADD-819B-56096259D6ADQ33569608-8B9063A2-77DC-404B-8AA4-A2E36F4C59C9Q33592538-2522A322-8159-40A6-8717-3C3778E12DE5Q33614523-4D406628-DF4E-4ED3-BEF8-D5BF492DE38DQ33787253-0A8349B8-9810-412D-8BB7-C860EC157648Q33826820-215E3267-15F5-4E6B-B911-D2AECD80A595Q33964297-BEA057EE-CDD5-4499-BB75-86FCCEA7BAB9Q34064292-A06C788C-B78D-43A6-94FA-689E572DDB1DQ34096338-AEF9F7E9-4A23-402B-BCFA-9ED32E6C30C9Q34098005-8A7C90ED-9879-42EF-8647-8DDA6BB2E0BBQ34217711-A5A31AC5-0505-40FB-9E93-CC5E9A6204DEQ34223125-7BC2C43F-D14C-466B-9666-1416D2265FD6Q34329254-40F26353-F025-4191-974E-59C4F143AE47Q34440371-7ABAB41C-6846-4542-8A92-B7290E4E8F24Q34460818-B547BC58-C941-4844-B7BD-2206FB47B767Q34461352-1E6C65D3-E734-42F6-800E-C51E8F18759CQ34626206-04E38862-1E1A-4096-9DDD-8C6ABE3AC5EBQ34708261-C88023E6-773D-4084-8444-EFA4D5462612Q34745605-9CEFAFA5-5D9E-44E5-A3B1-A8D29EDEE78EQ34803524-BFEEBEEA-AFE4-4337-BAA7-6203654A827DQ34974262-F552FCF7-AF27-403E-8287-5F00C67AED6AQ35030310-0226AE8D-510C-419F-AFBE-97ED1194F840Q35086073-7B67CF11-9E8A-4D48-BB36-DCF3EA9547D8Q35093148-3CD0649C-4CC4-43E1-9EB6-0F8F66260B97
P2860
Regulation of cholesterol and sphingomyelin metabolism by amyloid-beta and presenilin.
description
2005 nî lūn-bûn
@nan
2005年の論文
@ja
2005年学术文章
@wuu
2005年学术文章
@zh-cn
2005年学术文章
@zh-hans
2005年学术文章
@zh-my
2005年学术文章
@zh-sg
2005年學術文章
@yue
2005年學術文章
@zh
2005年學術文章
@zh-hant
name
Regulation of cholesterol and sphingomyelin metabolism by amyloid-beta and presenilin.
@en
Regulation of cholesterol and sphingomyelin metabolism by amyloid-beta and presenilin.
@nl
type
label
Regulation of cholesterol and sphingomyelin metabolism by amyloid-beta and presenilin.
@en
Regulation of cholesterol and sphingomyelin metabolism by amyloid-beta and presenilin.
@nl
prefLabel
Regulation of cholesterol and sphingomyelin metabolism by amyloid-beta and presenilin.
@en
Regulation of cholesterol and sphingomyelin metabolism by amyloid-beta and presenilin.
@nl
P2093
P50
P356
P1433
P1476
Regulation of cholesterol and sphingomyelin metabolism by amyloid-beta and presenilin.
@en
P2093
Andreas J Pätzold
Eva G Zinser
Heike S Grimm
Jakob A Tschäpe
Marcus O W Grimm
Riikka Halonen
Ulrike Müller
P2888
P304
P356
10.1038/NCB1313
P577
2005-11-01T00:00:00Z